The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project

Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. We sought to determine t...

Full description

Saved in:
Bibliographic Details
Published inJournal of allergy and clinical immunology Vol. 122; no. 6; pp. 1161 - 1165
Main Authors Decker, Wyatt W., Campbell, Ronna L., Manivannan, Veena, Luke, Anuradha, St. Sauver, Jennifer L., Weaver, Amy, Bellolio, M. Fernanda, Bergstralh, Eric J., Stead, Latha G., Li, James T.C.
Format Journal Article
LanguageEnglish
Published New York, NY Mosby, Inc 01.12.2008
Elsevier
Elsevier Limited
Subjects
Adolescent
Adult
Age
Age Factors
Aged
Allergies
Allergy and Immunology
anaphylaxis
Anaphylaxis - epidemiology
Anaphylaxis - etiology
Asthma
Biological and medical sciences
Cardiac arrhythmia
Cause
Child
Child, Preschool
Codes
Contrast Media - adverse effects
Drug Hypersensitivity - complications
Drug Hypersensitivity - epidemiology
Dysphagia
Epidemiology
Family medical history
Female
Food
Food allergies
Food Hypersensitivity - complications
Food Hypersensitivity - epidemiology
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Incidence
Infant
Insect Bites and Stings - complications
Insect Bites and Stings - epidemiology
Male
Medical records
Medical sciences
Middle Aged
Minnesota - epidemiology
Older people
Patients
Population
Retrospective Studies
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Minnesota
United States
North America
America
incidence
anaphylaxis
Cause
Allergy
Immunopathology
Anaphylaxis
Immunology
Etiology
Epidemiology
Incidence
Online AccessGet full text

Cover

Abstract Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. We sought to determine the incidence and cause of anaphylaxis over a 10-year period. We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement. Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), “other” causes accounted for 9% (19 cases), and “unknown” causes accounted for 25.1% (53 cases). The “other” group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 ( P = .03). The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
AbstractList Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. Objective - We sought to determine the incidence and cause of anaphylaxis over a 10-year period. Methods - We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement. Results - Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), "other" causes accounted for 9% (19 cases), and "unknown" causes accounted for 25.1% (53 cases). The "other" group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 (P = .03). Conclusion - The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events.BACKGROUNDReported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events.We sought to determine the incidence and cause of anaphylaxis over a 10-year period.OBJECTIVEWe sought to determine the incidence and cause of anaphylaxis over a 10-year period.We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement.METHODSWe performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement.Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), "other" causes accounted for 9% (19 cases), and "unknown" causes accounted for 25.1% (53 cases). The "other" group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 (P = .03).RESULTSTwo hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), "other" causes accounted for 9% (19 cases), and "unknown" causes accounted for 25.1% (53 cases). The "other" group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 (P = .03).The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.CONCLUSIONThe overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. We sought to determine the incidence and cause of anaphylaxis over a 10-year period. We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement. Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), "other" causes accounted for 9% (19 cases), and "unknown" causes accounted for 25.1% (53 cases). The "other" group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 (P = .03). The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
Background Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. Objective We sought to determine the incidence and cause of anaphylaxis over a 10-year period. Methods We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement. Results Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), "other" causes accounted for 9% (19 cases), and "unknown" causes accounted for 25.1% (53 cases). The "other" group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 (P= .03). Conclusion The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but has not been well characterized because of a lack of a standard definition and deficiencies in reporting of events. We sought to determine the incidence and cause of anaphylaxis over a 10-year period. We performed a population-based incidence study that was conducted in Rochester, Minnesota, from 1990 through 2000. Anaphylaxis episodes were identified on the basis of symptoms and signs of mast cell and basophil mediator release plus mucocutaneous, gastrointestinal tract, respiratory tract, or cardiovascular system involvement. Two hundred eleven cases of anaphylaxis were identified (55.9% in female subjects). The mean age was 29.3 years (SD, 18.2 years; range, 0.8-78.2 years). The overall age- and sex-adjusted incidence rate was 49.8 (95% CI, 45.0-54.5) per 100,000 person-years. Age-specific rates were highest for ages 0 to 19 years (70 per 100,000 person-years). Ingested foods accounted for 33.2% (70 cases), insect stings accounted for 18.5% (39 cases), medication accounted for 13.7% (29 cases), radiologic contrast agent accounted for 0.5% (1 case), “other” causes accounted for 9% (19 cases), and “unknown” causes accounted for 25.1% (53 cases). The “other” group included cats, latex, cleaning agents, environmental allergens, and exercise. There was an increase in the annual incidence rate during the study period from 46.9 per 100,000 persons in 1990 to 58.9 per 100,000 persons in 2000 ( P = .03). The overall incidence rate is 49.8 per 100,000 person-years, which is higher than previously reported. The annual incidence rate is also increasing. Food and insect stings continue to be major inciting agents for anaphylaxis.
Author Manivannan, Veena
Bellolio, M. Fernanda
Campbell, Ronna L.
Decker, Wyatt W.
Luke, Anuradha
Bergstralh, Eric J.
Li, James T.C.
Weaver, Amy
St. Sauver, Jennifer L.
Stead, Latha G.
AuthorAffiliation c Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minn
d Department of Internal Medicine, Division of Allergic Diseases, Mayo Clinic College of Medicine, Rochester, Minn
a Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
b Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, Minn
AuthorAffiliation_xml – name: d Department of Internal Medicine, Division of Allergic Diseases, Mayo Clinic College of Medicine, Rochester, Minn
– name: a Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– name: b Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, Minn
– name: c Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minn
Author_xml – sequence: 1
  givenname: Wyatt W.
  surname: Decker
  fullname: Decker, Wyatt W.
  email: decker.wyatt@mayo.edu
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 2
  givenname: Ronna L.
  surname: Campbell
  fullname: Campbell, Ronna L.
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 3
  givenname: Veena
  surname: Manivannan
  fullname: Manivannan, Veena
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 4
  givenname: Anuradha
  surname: Luke
  fullname: Luke, Anuradha
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 5
  givenname: Jennifer L.
  surname: St. Sauver
  fullname: St. Sauver, Jennifer L.
  organization: Department of Health Sciences Research, Division of Epidemiology, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 6
  givenname: Amy
  surname: Weaver
  fullname: Weaver, Amy
  organization: Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 7
  givenname: M. Fernanda
  surname: Bellolio
  fullname: Bellolio, M. Fernanda
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 8
  givenname: Eric J.
  surname: Bergstralh
  fullname: Bergstralh, Eric J.
  organization: Department of Health Sciences Research, Division of Biostatistics, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 9
  givenname: Latha G.
  surname: Stead
  fullname: Stead, Latha G.
  organization: Department of Emergency Medicine, Mayo Clinic College of Medicine, Rochester, Minn
– sequence: 10
  givenname: James T.C.
  surname: Li
  fullname: Li, James T.C.
  organization: Department of Internal Medicine, Division of Allergic Diseases, Mayo Clinic College of Medicine, Rochester, Minn
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20993258$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/18992928$$D View this record in MEDLINE/PubMed
BookMark eNqFUl1vEzEQPKEimhb-AA_IEoInEta-D9sVqlRV5UMqAkHeLce31_i42Ff7UpF_j08JASLRPln2zox3d-YkO3LeYZY9pzCjQKu37azVxs4YgJiBnEGRP8omFCSfVoKVR9kEQNJpxQt5nJ3E2EK650I-yY6pkJJJJiZZnC-R4GB95282RLuaWGdsjc4g8U160P1y0-mfNqYC-ebNEuOA4Q35bJ3D6Ad9Ri5IwN6HgTTBr8iQBPc4ctUnsdVO_mvwLZrhafa40V3EZ7vzNJu_v5pffpxef_nw6fLiemo4LYapoPlCNxoEa0Sec85raLgutE5j1GhKuuBMNHmOi2ZBC4HImBBFXpWNSXWWn2bnW9l-vVhhbdANQXeqD3alw0Z5bdW_FWeX6sbfKcahKCRPAq93AsHfrtM8amWjwa7TDv06qkoKyakoHwRSWdIcmEzAlwfA1q-DS0tQtIRCgKyqsfEXfze-7_i3awnwagfQ0eiuCTp5Fvc4BlLmrBxxYoszwccYsFHGDjqZPc5rO0VBjUFSrRqDpMYgKZAqBSlR2QF138V9pHdbEiZX7ywGFY0do1TbkHxXtbf3088P6KazzqYJf-AG459VqcgUqO9jvMd0gwDKCxh9OPu_wEO__wL4Dwr5
CODEN JACIBY
CitedBy_id crossref_primary_10_1016_j_jaip_2016_05_006
crossref_primary_10_1016_j_reval_2011_01_005
crossref_primary_10_1007_s15011_018_1959_2
crossref_primary_10_1016_j_pedhc_2012_12_011
crossref_primary_10_1111_j_1365_2222_2011_03930_x
crossref_primary_10_1016_S1959_5182_12_58698_8
crossref_primary_10_1007_s11882_024_01126_0
crossref_primary_10_1007_s12634_017_5390_6
crossref_primary_10_1016_j_jaci_2009_01_001
crossref_primary_10_1016_j_jaci_2009_05_028
crossref_primary_10_3389_fimmu_2019_00750
crossref_primary_10_1097_CCM_0000000000001822
crossref_primary_10_1016_j_anai_2009_11_023
crossref_primary_10_1016_j_ijbiomac_2021_01_027
crossref_primary_10_1007_s11882_010_0112_4
crossref_primary_10_3390_medicina56120695
crossref_primary_10_1111_j_1398_9995_2012_02795_x
crossref_primary_10_1007_s40521_018_0167_3
crossref_primary_10_1097_ACI_0000000000000280
crossref_primary_10_1007_s40264_018_0758_8
crossref_primary_10_1097_PHH_0000000000001137
crossref_primary_10_1111_all_16152
crossref_primary_10_1111_all_12475
crossref_primary_10_1097_WOX_0b013e318211496c
crossref_primary_10_1111_j_1365_2125_2010_03774_x
crossref_primary_10_1016_j_anai_2018_09_452
crossref_primary_10_1016_j_iac_2023_04_010
crossref_primary_10_1007_s00106_012_2579_x
crossref_primary_10_1016_j_jaci_2015_07_048
crossref_primary_10_1016_j_alit_2022_02_002
crossref_primary_10_1007_s40521_022_00305_6
crossref_primary_10_1007_s00281_012_0319_7
crossref_primary_10_1007_s11298_016_5749_4
crossref_primary_10_1016_j_intimp_2014_01_014
crossref_primary_10_4168_aard_2018_6_S1_S21
crossref_primary_10_1002_14651858_CD007596_pub3
crossref_primary_10_1016_j_anai_2016_09_444
crossref_primary_10_1016_j_jaip_2023_05_004
crossref_primary_10_1016_S0001_4079_19_32380_5
crossref_primary_10_1177_154193121005401226
crossref_primary_10_1111_j_1365_2222_2011_03954_x
crossref_primary_10_1111_j_1398_9995_2010_02422_x
crossref_primary_10_3389_falgy_2023_1249280
crossref_primary_10_1016_j_waojou_2024_100980
crossref_primary_10_1016_j_jaci_2009_06_044
crossref_primary_10_1016_j_jaci_2017_12_971
crossref_primary_10_1111_all_12924
crossref_primary_10_1002_clt2_12052
crossref_primary_10_1177_0333102411421683
crossref_primary_10_1017_S1049023X2100087X
crossref_primary_10_1016_S1081_1206_10_60358_4
crossref_primary_10_1016_j_anai_2016_10_025
crossref_primary_10_5847_wjem_j_issn_1920_8642_2013_02_003
crossref_primary_10_1016_j_iac_2011_11_008
crossref_primary_10_1159_000494130
crossref_primary_10_3390_ijms231710163
crossref_primary_10_1136_bcr_2012_007055
crossref_primary_10_1097_SHK_0000000000000899
crossref_primary_10_1016_j_jpeds_2016_09_028
crossref_primary_10_1111_pai_13034
crossref_primary_10_1016_j_jaci_2011_04_049
crossref_primary_10_1111_all_12012
crossref_primary_10_3390_cells8060546
crossref_primary_10_1007_s11882_011_0230_7
crossref_primary_10_1097_ACI_0b013e32832d2bc7
crossref_primary_10_1111_all_12015
crossref_primary_10_1111_j_1399_3038_2011_01181_x
crossref_primary_10_52420_2071_5943_2021_20_5_63_67
crossref_primary_10_1016_j_jaci_2008_12_025
crossref_primary_10_1016_j_jaci_2009_10_056
crossref_primary_10_1586_eci_09_12
crossref_primary_10_4097_kjae_2015_68_5_496
crossref_primary_10_1097_ACI_0b013e32832eb836
crossref_primary_10_4168_aard_2018_6_1_4
crossref_primary_10_1097_ACI_0000000000000176
crossref_primary_10_1016_j_jaip_2023_05_012
crossref_primary_10_1016_j_iac_2014_01_012
crossref_primary_10_1016_j_jtumed_2014_03_011
crossref_primary_10_1016_j_anai_2010_05_004
crossref_primary_10_1016_j_jaci_2011_09_018
crossref_primary_10_1111_j_1399_3038_2012_01315_x
crossref_primary_10_1111_pai_12011
crossref_primary_10_1016_j_anai_2015_05_006
crossref_primary_10_1097_MD_0000000000005750
crossref_primary_10_1111_pai_12013
crossref_primary_10_1016_j_foodqual_2011_01_009
crossref_primary_10_1016_j_waojou_2020_100480
crossref_primary_10_1016_j_jaci_2010_12_1098
crossref_primary_10_1080_10408398_2012_657807
crossref_primary_10_1097_MD_0000000000014114
crossref_primary_10_1016_j_ymeth_2013_07_033
crossref_primary_10_1007_s40521_016_0094_0
crossref_primary_10_1055_a_1397_0754
crossref_primary_10_1016_j_amjmed_2013_09_007
crossref_primary_10_1016_j_jeurea_2014_01_005
crossref_primary_10_4168_aair_2015_7_1_1
crossref_primary_10_1002_14651858_CD008935_pub2
crossref_primary_10_1016_j_amjmed_2013_09_008
crossref_primary_10_1093_pch_17_1_29
crossref_primary_10_1016_j_anai_2015_05_013
crossref_primary_10_2500_ajra_2016_30_4336
crossref_primary_10_1016_j_anai_2022_03_020
crossref_primary_10_7759_cureus_77818
crossref_primary_10_1111_1541_4337_12045
crossref_primary_10_1016_j_allmed_2025_100034
crossref_primary_10_1016_j_alergo_2015_11_002
crossref_primary_10_1016_j_amjmed_2013_09_011
crossref_primary_10_3389_fphar_2021_768643
crossref_primary_10_1016_j_trsl_2016_01_001
crossref_primary_10_1177_2150129712452134
crossref_primary_10_1177_1059840520986746
crossref_primary_10_1016_j_jaci_2008_10_019
crossref_primary_10_1016_j_jaci_2010_02_009
crossref_primary_10_1007_s40521_015_0053_1
crossref_primary_10_1007_s00281_012_0320_1
crossref_primary_10_1111_j_1398_9995_2010_02424_x
crossref_primary_10_1007_s40521_019_00209_y
crossref_primary_10_1016_j_anai_2012_11_018
crossref_primary_10_1111_j_1365_2222_2012_03930_x
crossref_primary_10_1155_2012_858306
crossref_primary_10_1007_s00228_012_1376_5
crossref_primary_10_1111_cea_12788
crossref_primary_10_1016_j_otc_2011_03_001
crossref_primary_10_1542_peds_2010_2575
crossref_primary_10_1016_j_aat_2016_12_003
crossref_primary_10_1016_j_jaci_2010_03_015
crossref_primary_10_1007_s40521_016_0093_1
crossref_primary_10_1111_pai_12284
crossref_primary_10_1097_ACI_0b013e32832db95a
crossref_primary_10_1016_j_lpm_2012_11_012
crossref_primary_10_1016_j_jaip_2013_03_006
crossref_primary_10_1186_s40413_018_0202_7
crossref_primary_10_1001_jamanetworkopen_2019_13951
crossref_primary_10_1097_ACI_0b013e32834877c3
crossref_primary_10_1016_j_jaci_2014_05_013
crossref_primary_10_1016_j_jacig_2022_09_002
crossref_primary_10_1111_cea_12418
crossref_primary_10_1097_ACI_0b013e32834a41a1
crossref_primary_10_1097_MOP_0b013e32833069a8
crossref_primary_10_1111_head_14539
crossref_primary_10_1111_j_1600_065X_2011_01028_x
crossref_primary_10_29262_ram_v66i6_588
crossref_primary_10_1016_j_jeurea_2015_03_009
crossref_primary_10_1042_BSR20181113
crossref_primary_10_1111_j_1610_0387_2012_08045_x
crossref_primary_10_1136_bmjpo_2017_000077
crossref_primary_10_1016_j_jaci_2016_04_029
crossref_primary_10_4168_aair_2015_7_1_22
crossref_primary_10_1080_1744666X_2019_1641406
crossref_primary_10_1586_eri_11_153
crossref_primary_10_1007_s15007_014_0542_8
crossref_primary_10_1155_2015_231862
crossref_primary_10_1016_j_jaci_2009_02_035
crossref_primary_10_1016_j_iac_2011_12_001
crossref_primary_10_1136_jcp_2009_068577
crossref_primary_10_1016_j_jaci_2020_01_017
crossref_primary_10_1016_j_mehy_2018_08_006
crossref_primary_10_1016_j_jaip_2014_07_011
crossref_primary_10_1111_pai_12211
crossref_primary_10_1089_ped_2015_0569
crossref_primary_10_1007_s15006_017_9600_y
crossref_primary_10_1007_s00060_016_5168_x
crossref_primary_10_1177_1367493512448128
crossref_primary_10_1111_pai_13307
crossref_primary_10_1007_s11882_012_0274_3
crossref_primary_10_1111_all_12069
crossref_primary_10_1111_cea_12245
crossref_primary_10_1016_j_anai_2018_01_029
crossref_primary_10_1016_j_iac_2021_09_007
crossref_primary_10_1016_j_jaci_2013_08_016
crossref_primary_10_1016_j_jaci_2011_01_034
crossref_primary_10_1016_j_jaip_2015_05_012
crossref_primary_10_3390_molecules25051028
crossref_primary_10_1177_2054270415593443
crossref_primary_10_1007_s40629_014_0009_1
crossref_primary_10_1186_s13223_017_0223_8
crossref_primary_10_1007_s12016_013_8354_2
crossref_primary_10_1016_j_jaci_2009_12_981
crossref_primary_10_47102_annals_acadmedsg_V45N12p542
crossref_primary_10_1111_cea_12477
crossref_primary_10_1177_03635465211059195
crossref_primary_10_1542_peds_2009_2832
crossref_primary_10_1007_s00281_012_0338_4
crossref_primary_10_1016_j_fct_2013_08_023
crossref_primary_10_1007_s12016_015_8503_x
crossref_primary_10_1016_j_jaip_2021_11_031
crossref_primary_10_1186_s40413_017_0171_2
crossref_primary_10_1016_j_reval_2010_01_026
crossref_primary_10_1111_pai_13685
crossref_primary_10_1016_j_anai_2019_11_026
crossref_primary_10_1017_S1049023X25000184
crossref_primary_10_1111_j_1365_2222_2011_03912_x
crossref_primary_10_7581_pard_2012_22_3_215
crossref_primary_10_1016_j_jaip_2013_10_001
crossref_primary_10_1111_cea_12225
crossref_primary_10_2165_11640800_000000000_00000
crossref_primary_10_1111_cea_13673
crossref_primary_10_1016_j_jaci_2010_11_044
crossref_primary_10_1517_14656566_2013_833186
crossref_primary_10_1016_j_anai_2013_06_020
crossref_primary_10_1111_j_1398_9995_2010_02332_x
crossref_primary_10_1007_s00103_011_1436_5
crossref_primary_10_21508_1027_4065_2020_65_3_5_10
crossref_primary_10_1016_j_pop_2016_04_008
crossref_primary_10_1016_j_jaci_2010_10_007
crossref_primary_10_1097_MD_0000000000030224
crossref_primary_10_38181_2223_2427_2020_1_59_63
crossref_primary_10_1186_s40413_018_0200_9
crossref_primary_10_1002_ebch_1925
crossref_primary_10_1155_2018_5631372
crossref_primary_10_1016_j_chroma_2011_06_033
crossref_primary_10_1007_s15007_020_4750_0
crossref_primary_10_1097_ACI_0b013e3283535aaf
crossref_primary_10_1016_j_reval_2016_12_001
crossref_primary_10_1111_phn_12073
crossref_primary_10_1097_ACI_0000000000000575
crossref_primary_10_3810_pgm_2014_07_2785
crossref_primary_10_1111_1552_6909_12732
crossref_primary_10_3389_falgy_2022_840999
crossref_primary_10_1007_s11739_013_0978_y
crossref_primary_10_1186_s13052_014_0100_8
crossref_primary_10_1016_j_anai_2015_07_019
crossref_primary_10_1016_j_anai_2013_09_026
crossref_primary_10_1016_j_aller_2016_06_004
crossref_primary_10_36691_RJA607
crossref_primary_10_1007_s11882_023_01122_w
crossref_primary_10_1111_cea_12842
crossref_primary_10_1007_s12245_009_0093_z
crossref_primary_10_1016_j_jaci_2015_10_027
crossref_primary_10_33151_ajp_12_3_235
crossref_primary_10_1016_S1081_1206_10_60512_1
crossref_primary_10_1016_j_jaci_2015_04_029
crossref_primary_10_1007_s40355_012_0007_9
crossref_primary_10_1007_s40629_020_00158_y
crossref_primary_10_1016_S1081_1206_10_60265_7
crossref_primary_10_1016_j_jaci_2009_04_004
crossref_primary_10_1586_eci_09_73
crossref_primary_10_1016_j_jaip_2013_06_011
crossref_primary_10_1111_cea_12036
crossref_primary_10_1007_s00105_012_2449_1
crossref_primary_10_1016_j_jaci_2016_02_015
crossref_primary_10_1021_jf405773b
crossref_primary_10_1016_j_jaci_2009_08_025
crossref_primary_10_1016_j_appet_2021_105177
crossref_primary_10_1093_aje_kwac182
crossref_primary_10_1016_j_jaci_2009_08_028
crossref_primary_10_1007_s11882_009_0027_0
crossref_primary_10_1016_j_vaccine_2013_09_066
crossref_primary_10_1371_journal_pone_0035778
crossref_primary_10_1016_j_anai_2020_06_008
crossref_primary_10_1186_s12948_022_00170_3
crossref_primary_10_36691_RJA508
crossref_primary_10_1177_0009922818770823
crossref_primary_10_1016_j_anai_2016_11_025
crossref_primary_10_12968_jpar_2012_4_5_287
crossref_primary_10_1016_j_jaci_2009_01_071
crossref_primary_10_1016_j_iac_2011_10_002
crossref_primary_10_1097_ACI_0b013e32833a6c72
crossref_primary_10_1177_0009922814527502
crossref_primary_10_1097_ACI_0000000000000241
crossref_primary_10_1016_j_amjmed_2016_07_018
crossref_primary_10_3389_fphar_2022_845689
crossref_primary_10_1016_j_iac_2014_09_010
crossref_primary_10_3238_arztebl_2014_0367
crossref_primary_10_1177_1059840516641190
crossref_primary_10_4168_aair_2013_5_1_3
crossref_primary_10_4168_aard_2015_3_3_187
crossref_primary_10_1007_s11882_010_0154_7
crossref_primary_10_1097_ACI_0b013e328362b8aa
crossref_primary_10_1111_j_1365_2222_2012_03968_x
crossref_primary_10_15591_mtp_2016_023
crossref_primary_10_1586_1744666X_2013_828871
crossref_primary_10_3390_diagnostics13213307
crossref_primary_10_1542_peds_2012_2585
crossref_primary_10_1016_j_anai_2016_11_006
crossref_primary_10_1007_s11882_012_0284_1
crossref_primary_10_1016_j_anai_2011_01_011
crossref_primary_10_1007_s00216_012_6129_x
crossref_primary_10_1097_PEC_0b013e318267f689
crossref_primary_10_1186_s13223_017_0189_6
crossref_primary_10_4168_aair_2018_10_2_137
crossref_primary_10_1016_j_resuscitation_2016_12_020
crossref_primary_10_1007_s00112_016_0200_1
crossref_primary_10_25259_KPJ_24_2021
Cites_doi 10.1016/j.jaci.2003.11.033
10.1016/j.jaci.2005.01.009
10.1046/j.1365-2222.2003.01671.x
10.4065/71.3.266
10.1016/S1081-1206(10)61086-1
10.1136/thx.2004.038844
10.1016/S0091-6749(99)70392-1
10.1038/scientificamerican1081-54
10.1136/thx.2006.066407
10.1136/bmj.320.7247.1441
10.1016/j.jaci.2005.12.1303
10.1016/j.jaci.2007.07.040
10.1016/j.jaci.2007.07.015
ContentType Journal Article
Copyright 2008 American Academy of Allergy, Asthma & Immunology
American Academy of Allergy, Asthma & Immunology
2009 INIST-CNRS
Copyright Elsevier Limited Dec 2008
Copyright_xml – notice: 2008 American Academy of Allergy, Asthma & Immunology
– notice: American Academy of Allergy, Asthma & Immunology
– notice: 2009 INIST-CNRS
– notice: Copyright Elsevier Limited Dec 2008
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
DOI 10.1016/j.jaci.2008.09.043
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Entomology Abstracts (Full archive)
Immunology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Entomology Abstracts
AIDS and Cancer Research Abstracts
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Premium
Immunology Abstracts
MEDLINE - Academic
DatabaseTitleList AIDS and Cancer Research Abstracts
MEDLINE - Academic
MEDLINE
Entomology Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1097-6825
EndPage 1165
ExternalDocumentID PMC2704497
3239275821
18992928
20993258
10_1016_j_jaci_2008_09_043
S0091674908017405
1_s2_0_S0091674908017405
Genre Research Support, Non-U.S. Gov't
Journal Article
GeographicLocations Minnesota
United States
North America
America
GeographicLocations_xml – name: Minnesota
GrantInformation_xml – fundername: NIAMS NIH HHS
  grantid: R01 AR030582
GroupedDBID ---
--K
--M
-~X
.1-
.55
.FO
.GJ
.XZ
.~1
0R~
1B1
1P~
1RT
1~.
1~5
354
3O-
4.4
457
4G.
53G
5GY
5RE
5VS
7-5
71M
8F7
8FE
8FH
8P~
9JM
AAAJQ
AABNK
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AARKO
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABOCM
ABWVN
ABXDB
ACDAQ
ACGFO
ACGFS
ACIEU
ACPRK
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADFRT
ADMUD
ADNMO
ADVLN
ADXHL
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AFFNX
AFJKZ
AFPUW
AFRAH
AFRHN
AFTJW
AFXIZ
AGCQF
AGEKW
AGHFR
AGQPQ
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
BNPGV
BPHCQ
BVXVI
C45
CAG
CJTIS
COF
CS3
DU5
EBS
EFJIC
EFKBS
EJD
EO8
EO9
EP2
EP3
EX3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HDU
HMK
HMO
HVGLF
HZ~
IHE
J1W
J5H
K-O
KOM
L7B
LK8
LUGTX
M27
M41
MO0
N4W
N9A
O-L
O9-
O9~
OAUVE
OBH
ODZKP
OHH
OHT
OK0
OK1
OVD
OZT
P-8
P-9
P2P
PC.
PQQKQ
PROAC
Q38
R2-
ROL
RPZ
SAE
SCC
SDF
SDG
SDP
SEL
SES
SEW
SJN
SPCBC
SSH
SSI
SSZ
T5K
TEORI
TWZ
UGJ
UNMZH
UV1
WH7
WOW
WUQ
X7M
XFW
YOC
YQI
YQJ
Z5R
ZGI
ZXP
ZY1
~02
~G-
~KM
AACTN
RIG
AAYXX
AGRNS
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7SS
7T5
H94
K9.
NAPCQ
7X8
5PM
ID FETCH-LOGICAL-c714t-813bafa082f833777d0f7a4aa009dec51b728f33ebfb148ee22884365fc9de23
IEDL.DBID AIKHN
ISSN 0091-6749
1097-6825
IngestDate Thu Aug 21 14:37:54 EDT 2025
Wed Jul 30 10:22:39 EDT 2025
Mon Jul 21 10:10:55 EDT 2025
Wed Aug 13 11:20:02 EDT 2025
Fri May 30 10:59:34 EDT 2025
Mon Jul 21 09:14:34 EDT 2025
Thu Apr 24 23:08:39 EDT 2025
Tue Jul 01 04:31:45 EDT 2025
Sun Apr 06 06:53:39 EDT 2025
Wed Apr 02 07:43:51 EDT 2025
Tue Aug 26 17:58:55 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords incidence
anaphylaxis
Cause
Allergy
Immunopathology
Anaphylaxis
Immunology
Etiology
Epidemiology
Incidence
Language English
License https://www.elsevier.com/tdm/userlicense/1.0
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c714t-813bafa082f833777d0f7a4aa009dec51b728f33ebfb148ee22884365fc9de23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Article-2
ObjectType-Feature-1
content type line 23
OpenAccessLink http://www.jacionline.org/article/S0091674908017405/pdf
PMID 18992928
PQID 1504809662
PQPubID 105664
PageCount 5
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_2704497
proquest_miscellaneous_69897185
proquest_miscellaneous_19513029
proquest_journals_1504809662
pubmed_primary_18992928
pascalfrancis_primary_20993258
crossref_citationtrail_10_1016_j_jaci_2008_09_043
crossref_primary_10_1016_j_jaci_2008_09_043
elsevier_sciencedirect_doi_10_1016_j_jaci_2008_09_043
elsevier_clinicalkeyesjournals_1_s2_0_S0091674908017405
elsevier_clinicalkey_doi_10_1016_j_jaci_2008_09_043
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2008-12-01
PublicationDateYYYYMMDD 2008-12-01
PublicationDate_xml – month: 12
  year: 2008
  text: 2008-12-01
  day: 01
PublicationDecade 2000
PublicationPlace New York, NY
PublicationPlace_xml – name: New York, NY
– name: United States
– name: St. Louis
PublicationTitle Journal of allergy and clinical immunology
PublicationTitleAlternate J Allergy Clin Immunol
PublicationYear 2008
Publisher Mosby, Inc
Elsevier
Elsevier Limited
Publisher_xml – name: Mosby, Inc
– name: Elsevier
– name: Elsevier Limited
References Mullins (bib5) 2003; 22
Yocum, Butterfield, Klein, Volcheck, Schroeder, Silverstein (bib4) 1999; 104
Kurland, Molgaard (bib9) 1981; 245
Lieberman, Camargo, Bohlke, Jick, Miller, Sheikh (bib10) 2006; 97
Sampson, Muñoz-Furlong, Campbell, Adkinson, Bock, Branum (bib2) 2006; 117
Bohlke, Davis, DeStefano, Marcy, Braun, Thompson (bib3) 2004; 113
Poulos, Waters, Correll, Loblay, Marks (bib14) 2007; 120
Gupta, Sheikh, Strachan, Anderson (bib11) 2007; 62
Sheikh, Alves (bib12) 2000; 320
Anderson, Gupta, Strachan, Limb (bib7) 2007; 62
Melton (bib8) 1996; 71
Sicherer, Sampson (bib6) 2007; 120
Wilson (bib13) 2000; 321
Sampson, Muñoz-Furlong, Bock, Schmitt, Bass, Chowdhury (bib1) 2005; 115
Sampson (10.1016/j.jaci.2008.09.043_bib1) 2005; 115
Bohlke (10.1016/j.jaci.2008.09.043_bib3) 2004; 113
Kurland (10.1016/j.jaci.2008.09.043_bib9) 1981; 245
Melton (10.1016/j.jaci.2008.09.043_bib8) 1996; 71
Anderson (10.1016/j.jaci.2008.09.043_bib7) 2007; 62
Poulos (10.1016/j.jaci.2008.09.043_bib14) 2007; 120
Yocum (10.1016/j.jaci.2008.09.043_bib4) 1999; 104
Wilson (10.1016/j.jaci.2008.09.043_bib13) 2000; 321
Mullins (10.1016/j.jaci.2008.09.043_bib5) 2003; 22
Sicherer (10.1016/j.jaci.2008.09.043_bib6) 2007; 120
Lieberman (10.1016/j.jaci.2008.09.043_bib10) 2006; 97
Sheikh (10.1016/j.jaci.2008.09.043_bib12) 2000; 320
Gupta (10.1016/j.jaci.2008.09.043_bib11) 2007; 62
Sampson (10.1016/j.jaci.2008.09.043_bib2) 2006; 117
19084110 - J Allergy Clin Immunol. 2008 Dec;122(6):1166-8. doi: 10.1016/j.jaci.2008.10.019.
19361842 - J Allergy Clin Immunol. 2009 May;123(5):1194; author reply 1194-5. doi: 10.1016/j.jaci.2009.02.035.
References_xml – volume: 113
  start-page: 536
  year: 2004
  end-page: 542
  ident: bib3
  article-title: Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization
  publication-title: J Allergy Clin Immunol
– volume: 71
  start-page: 266
  year: 1996
  end-page: 274
  ident: bib8
  article-title: History of the Rochester Epidemiology Project
  publication-title: Mayo Clin Proc
– volume: 120
  start-page: 491
  year: 2007
  end-page: 503
  ident: bib6
  article-title: Peanut allergy: emerging concepts and approaches for an apparent epidemic
  publication-title: J Allergy Clin Immunol
– volume: 62
  start-page: 85
  year: 2007
  end-page: 90
  ident: bib7
  article-title: 50 years of asthma: UK trends from 1955-2004
  publication-title: Thorax
– volume: 62
  start-page: 91
  year: 2007
  end-page: 96
  ident: bib11
  article-title: Time trends in allergic disorders in the UK
  publication-title: Thorax
– volume: 115
  start-page: 584
  year: 2005
  end-page: 591
  ident: bib1
  article-title: Symposium on the definition and management of anaphylaxis: summary report
  publication-title: J Allergy Clin Immunol
– volume: 97
  start-page: 596
  year: 2006
  end-page: 602
  ident: bib10
  article-title: Epidemiology of anaphylaxis: findings of the American Collage of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
  publication-title: Ann Allergy Asthma Immunol
– volume: 245
  start-page: 54
  year: 1981
  end-page: 63
  ident: bib9
  article-title: The patient record in epidemiology
  publication-title: Sci Am
– volume: 120
  year: 2007
  ident: bib14
  article-title: Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005
  publication-title: J Allergy Clin Immunol
– volume: 321
  start-page: 1021
  year: 2000
  end-page: 1022
  ident: bib13
  article-title: Upward trend in acute anaphylaxis continued in 1998-9
  publication-title: BMJ
– volume: 320
  start-page: 1441
  year: 2000
  ident: bib12
  article-title: Hospital admissions for acute anaphylaxis: time trend study
  publication-title: BMJ
– volume: 117
  start-page: 391
  year: 2006
  end-page: 397
  ident: bib2
  article-title: Second symposium on the definition and management of anaphylaxis: summary report: second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
  publication-title: J Allergy Clin Immunol
– volume: 104
  start-page: 452
  year: 1999
  end-page: 456
  ident: bib4
  article-title: Epidemiology of anaphylaxis in Olmsted County: a population-based study
  publication-title: J Allergy Clin Immunol
– volume: 22
  start-page: 1033
  year: 2003
  end-page: 1040
  ident: bib5
  article-title: Anaphylaxis: risk factors for recurrence
  publication-title: Clin Exp Allergy
– volume: 113
  start-page: 536
  year: 2004
  ident: 10.1016/j.jaci.2008.09.043_bib3
  article-title: Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2003.11.033
– volume: 115
  start-page: 584
  year: 2005
  ident: 10.1016/j.jaci.2008.09.043_bib1
  article-title: Symposium on the definition and management of anaphylaxis: summary report
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.01.009
– volume: 22
  start-page: 1033
  year: 2003
  ident: 10.1016/j.jaci.2008.09.043_bib5
  article-title: Anaphylaxis: risk factors for recurrence
  publication-title: Clin Exp Allergy
  doi: 10.1046/j.1365-2222.2003.01671.x
– volume: 71
  start-page: 266
  year: 1996
  ident: 10.1016/j.jaci.2008.09.043_bib8
  article-title: History of the Rochester Epidemiology Project
  publication-title: Mayo Clin Proc
  doi: 10.4065/71.3.266
– volume: 97
  start-page: 596
  year: 2006
  ident: 10.1016/j.jaci.2008.09.043_bib10
  article-title: Epidemiology of anaphylaxis: findings of the American Collage of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group
  publication-title: Ann Allergy Asthma Immunol
  doi: 10.1016/S1081-1206(10)61086-1
– volume: 62
  start-page: 91
  year: 2007
  ident: 10.1016/j.jaci.2008.09.043_bib11
  article-title: Time trends in allergic disorders in the UK
  publication-title: Thorax
  doi: 10.1136/thx.2004.038844
– volume: 104
  start-page: 452
  year: 1999
  ident: 10.1016/j.jaci.2008.09.043_bib4
  article-title: Epidemiology of anaphylaxis in Olmsted County: a population-based study
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/S0091-6749(99)70392-1
– volume: 245
  start-page: 54
  year: 1981
  ident: 10.1016/j.jaci.2008.09.043_bib9
  article-title: The patient record in epidemiology
  publication-title: Sci Am
  doi: 10.1038/scientificamerican1081-54
– volume: 62
  start-page: 85
  year: 2007
  ident: 10.1016/j.jaci.2008.09.043_bib7
  article-title: 50 years of asthma: UK trends from 1955-2004
  publication-title: Thorax
  doi: 10.1136/thx.2006.066407
– volume: 320
  start-page: 1441
  year: 2000
  ident: 10.1016/j.jaci.2008.09.043_bib12
  article-title: Hospital admissions for acute anaphylaxis: time trend study
  publication-title: BMJ
  doi: 10.1136/bmj.320.7247.1441
– volume: 321
  start-page: 1021
  year: 2000
  ident: 10.1016/j.jaci.2008.09.043_bib13
  article-title: Upward trend in acute anaphylaxis continued in 1998-9
  publication-title: BMJ
– volume: 117
  start-page: 391
  year: 2006
  ident: 10.1016/j.jaci.2008.09.043_bib2
  article-title: Second symposium on the definition and management of anaphylaxis: summary report: second National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2005.12.1303
– volume: 120
  year: 2007
  ident: 10.1016/j.jaci.2008.09.043_bib14
  article-title: Trends in hospitalizations for anaphylaxis, angioedema, and urticaria in Australia, 1993-1994 to 2004-2005
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2007.07.040
– volume: 120
  start-page: 491
  year: 2007
  ident: 10.1016/j.jaci.2008.09.043_bib6
  article-title: Peanut allergy: emerging concepts and approaches for an apparent epidemic
  publication-title: J Allergy Clin Immunol
  doi: 10.1016/j.jaci.2007.07.015
– reference: 19084110 - J Allergy Clin Immunol. 2008 Dec;122(6):1166-8. doi: 10.1016/j.jaci.2008.10.019.
– reference: 19361842 - J Allergy Clin Immunol. 2009 May;123(5):1194; author reply 1194-5. doi: 10.1016/j.jaci.2009.02.035.
SSID ssj0009389
Score 2.4531536
Snippet Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health implications but...
Background Reported incidences of anaphylaxis range from 3.2 to 20 per 100,000 population. The incidence and trend over time has meaningful public health...
SourceID pubmedcentral
proquest
pubmed
pascalfrancis
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 1161
SubjectTerms Adolescent
Adult
Age
Age Factors
Aged
Allergies
Allergy and Immunology
anaphylaxis
Anaphylaxis - epidemiology
Anaphylaxis - etiology
Asthma
Biological and medical sciences
Cardiac arrhythmia
Cause
Child
Child, Preschool
Codes
Contrast Media - adverse effects
Drug Hypersensitivity - complications
Drug Hypersensitivity - epidemiology
Dysphagia
Epidemiology
Family medical history
Female
Food
Food allergies
Food Hypersensitivity - complications
Food Hypersensitivity - epidemiology
Fundamental and applied biological sciences. Psychology
Fundamental immunology
Humans
Incidence
Infant
Insect Bites and Stings - complications
Insect Bites and Stings - epidemiology
Male
Medical records
Medical sciences
Middle Aged
Minnesota - epidemiology
Older people
Patients
Population
Retrospective Studies
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
Title The etiology and incidence of anaphylaxis in Rochester, Minnesota: A report from the Rochester Epidemiology Project
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0091674908017405
https://www.clinicalkey.es/playcontent/1-s2.0-S0091674908017405
https://dx.doi.org/10.1016/j.jaci.2008.09.043
https://www.ncbi.nlm.nih.gov/pubmed/18992928
https://www.proquest.com/docview/1504809662
https://www.proquest.com/docview/19513029
https://www.proquest.com/docview/69897185
https://pubmed.ncbi.nlm.nih.gov/PMC2704497
Volume 122
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELZKKyEkhHizUBYfuEHa-JF1zG1VtVpAWyFUpN4sO7FFqiq7alKpXPjtjGMnYaEtEtd4RknGk_HneGY-hN5S4VxWsDKBxYkmPHM2kVTYRDgzM8IWM2H9ie7yeLb4xj-dZqdb6KCvhfFplTH2h5jeRet4ZT9ac39dVb7GV_oUegmYB2C172O6Q5mcgWvvzD9-XhyPvXdZHlCwJIlXiLUzIc3rTBdVTKmUeylnN61P99e6Aau5QHdxHR79M63yt3Xq6CF6EAEmnod3eIS2bP0Y3V3GI_QnqAHHwLYNVSpY1yX2f9s7ZlG8cnDBN7A-11dVAwP4a0-o9R4vPUtXs2r1BzzH4agB--IUDBBylMOHI-XsD_wl_Od5ik6ODk8OFklkXkgKQXib5IQZ7TTAA5czJoQoUyc01xpsWNoiI0bQ3DFmjTOwn7KW0jznbJa5AsYpe4a261VtXyCcZ6UurclISSzXkphSAELOU66NAKyWTxDpza2K2JXck2Ocqz797Ez5KYp0mVLBFE3Qu0FnHXpy3CrN-llUfbUpxEcFS8atWuI6LdvET7xRRDVUpeovN5ygbNDc8OR_3nG64WLDq_niZkYzMNVu73NqfIrMNwWAPSudoDfDMIQIf-6ja7u6BBlA0Syl8mYJzyIKIAWe_Xlw4dGusB-nksLNxYZzDwK-PfnmSF1979qUU5FyLsXL_7THK3Svy83pUod20XZ7cWlfAwBszRTd2ftJpvEz_wV-IVxH
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaqIgESQrxZKK0P3CBt4sc65lZVrRboVggtUm-WndgiVZVdNalULvx2xrGTsNAWiWs8VpLxePzZ_mYGobdEOMcLWiawOJGEcWcTSYRNhDNTI2wxFdbf6M5PprNv7NMpP91AB30sjKdVRt8ffHrnreOTvajNvVVV-Rhf6Sn0EjAPwGqfx_QOg-nrZ-fuz5HnIWkeMLDMEi8eI2cCyetMF1UkVMrdlNGbVqcHK92AzlwodnEdGv2TVPnbKnX0CD2M8BLvhz94jDZs_QTdnccL9KeoAbPAtg0xKljXJfZn7V1dUbx08MCnrz7XV1UDDfhrX07rPZ77Gl3NstUf8D4OFw3Yh6ZgAJCjHD4cC87-wF_CKc8ztDg6XBzMklh3ISlExtokz6jRTgM4cDmlQogydUIzrUGHpS14ZgTJHaXWOAO7KWsJyXNGp9wV0E7oc7RZL2v7EuGcl7q0hmdlZpmWmSkF4OM8ZdoIQGr5BGW9ulURc5L70hjnqiefnSk_RLFYplQwRBP0buizChk5bpWm_SiqPtYUvKOCBePWXuK6XraJE7xRmWqIStVfRjhBfOi5Zsf_fOP2mokNv-ZDmynhoKqt3ubU-BXcpwSAHSuZoJ2hGRyEv_XRtV1eggxgaJoSebOEryEKEAW-_UUw4VGvsBsnksDLxZpxDwI-Ofl6S11975KUE5EyJsWr_9THDro3W8yP1fHHk8-v0f2OpdORiLbQZntxad8AFGzNdjfVfwFlT10L
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+etiology+and+incidence+of+anaphylaxis+in+Rochester%2C+Minnesota%3A+A+report+from+the+Rochester+Epidemiology+Project&rft.jtitle=Journal+of+allergy+and+clinical+immunology&rft.au=Decker%2C+Wyatt+W&rft.au=Campbell%2C+Ronna+L&rft.au=Manivan+nan%2C+Veena&rft.au=Luke%2C+Anuradha&rft.date=2008-12-01&rft.pub=Elsevier+Limited&rft.issn=0091-6749&rft.eissn=1097-6825&rft.volume=122&rft.issue=6&rft.spage=1161&rft_id=info:doi/10.1016%2Fj.jaci.2008.09.043&rft.externalDBID=NO_FULL_TEXT&rft.externalDocID=3239275821
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F00916749%2FS0091674908X00132%2Fcov150h.gif